Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5

Blood

Volumn 96, Issue 6, 2000, Pages 2277-2283

  Sexl, V ^a   Piekorz, R ^a   Moriggl, R ^a   Rohrer, J ^a   Brown, M P ^a   Bunting, K D ^a   Rothammer, K ^a   Roussel, M F ^a   Ihle, J N ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERLEUKIN 4; INTERLEUKIN 7; STAT5 PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE REARRANGEMENT; IMMUNOGLOBULIN PRODUCTION; LYMPHATIC SYSTEM TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034665676     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2277.h8002277_2277_2283     Document Type: Article

References (39)

1. Physiological role of interleukin-2, interleukin-4, and interleukin-7
2. STATs and gene regulation
3. Activated stat related transcription factors in acute leukemia
4. Constitutive activation of Stat5 by the bcr-abl oncogene in chronic myelogenous leukemia
5. Constitutive activation of Jaks and Stats in bcr-abl-expressing cell lines and peripheral blood cells derived from leukemic patients
6. Stat5a and Stat5b proteins have essential and non-essential, or redundant, roles in cytokine responses
7. Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7-deficient mice
8. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice
9. Interleukin-7 (IL-7) knockout mice: Implications for lymphopoiesis and organ-specific immunity
10. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
11. Murine B lymphopoiesis: Towards a unified model
12. Immune responses of IL-4, IL-5, IL-6 deficient mice
13. Immune responses in Interleukin 4-deficient mice
14. The interleukin-4 receptor activates Stat5 by a mechanism that relies upon common γ-chain
15. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells
16. Stat5 is required for IL-2 induced celt cycle progression of peripheral T cells
17. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells
18. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene
19. A stage-specific enhancer of immunoglobulin J chain is induced by interleukin-2 in a presecretor B cell stage
20. IL-7 reconstitutes multiple aspects of v-abl-mediated signaling
21. Signal transduction by wild-type and leukemogenic Abl proteins
22. Jak-Stat signaling induced by the v-abl oncogene
23. Activation of Stat transcription factors in oncogenic tyrosine kinase signaling
24. The viral and cellular forms of the Abelson (abl) oncogene
25. The biology of chronic myeloid leukemia
26. Ph positive acute lymphoblastic leukemia in adults: Molecular and clinical studies
27. Bcr-abl leads to constitutive activation of stat proteins and shares an epitope with tyrosine phosphorylated stats
28. Tyrosine phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines by bcr-abl
29. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
30. Signal transducer and activator of transcription (STAT)5 activation by bcr/abl is dependent on intact src homology (SH)3 and SH2 domains of bcr/abl and is required for leukemogenesis
31. Use of green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
32. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of cdk2
33. The immunoglobulin class switch: Beyond 'accessibility.' Immunity
34. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving p210 bcr/abl-transduced bone marrow
35. Efficient transplantation of bcr-abl-induced chronic myelogenous leukemia-like syndrome in mice
36. Bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple hemopoietic neoplasms in mice
37. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
38. Bcr-abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
39. Mouse oncostatin M: An immediate early gene induced by multiple cytokinesthrough the JAK-STAT5 pathway